Previous work has demonstrated mainly that 1,25(OH)2D3 inhibits β-catenin transcriptional activity by promoting VDR binding to β-catenin, promoting the translocation of β-catenin from the nucleus to the plasma membrane, and inducing of E-cadherin expression in several cancers [15,22,26]. The gene discussed is VDR; the disease is cancer.